Oragenics free cash flow OGEN

Cash from operations less capital spending, by quarter and over the last twelve months, from 2010.

Oragenics' free cash flow was −$15.4M over the twelve months to Dec 31, 2022.

In its latest quarter, Q4 FY22, it was −$2.4M.

Free cash flow over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	Free cash flow	On a year earlier	Last 12 months
Q4 FY22	Dec 31, 2022	−$2.4M	n/a	−$15.4M
Q3 FY22	Sep 30, 2022	−$3.8M	n/a	−$15.4M
Q2 FY22	Jun 30, 2022	−$3.4M	n/a	n/a
Q1 FY22	Mar 31, 2022	−$5.7M	n/a	n/a
Q4 FY21	Dec 31, 2021	−$2.5M	n/a	n/a
Q4 FY19	Dec 31, 2019	−$4M	n/a	n/a
Q3 FY19	Sep 30, 2019	−$3.4M	n/a	n/a
Q4 FY18	Dec 31, 2018	−$3M	n/a	n/a
Q4 FY16	Dec 31, 2016	−$2M	n/a	n/a
Q4 FY15	Dec 31, 2015	−$1.7M	n/a	−$5.3M
Q3 FY15	Sep 30, 2015	−$1.3M	n/a	−$4.9M
Q2 FY15	Jun 30, 2015	−$921.5K	n/a	−$4.7M

Companies in Healthcare nearest Oragenics' size, closest first, today.

Company	Free cash flow yield
OGENOragenics	n/m
OXBROXBRIDGE RE HOLDINGS	n/m
EDUCEducational Development	2.0%
GTIMGood Times Restaurants	19.3%
MDRRMedalist Diversified	n/m
BCGBinah Capital	30.9%
Peer median	19.3%

Cash from operations minus capital spending. The cash the company could hand back or reinvest.

Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.